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We have shown previously that the in vitro activity of the renal vitamin K-dependent y-glutamyl carboxylase 
toward synthetic oligopeptide substrates is stimulated by administration of either parathyroid hormone 
(PTH) or 1,25-dihydroxycholecalciferol [1,25(OH),D,] to rats [(1983) J. Biol. Chem. 258, 12783-127861. 
Here we report that administration of l,25(OH)*Dg to rats increases their levels of endogenous carboxylase 
substrate as well. Rats fed a vitamin D-deficient diet had highly elevated serum PTH levels while vitamin 
D-replete animals had undetectable levels. Furthermore, since PTH increases 1,25(OH),D, levels by stimu- 
lating renal 25-hydroxyvitamin D-la-hydroxylase, it is very likely that the stimulatory effects of PTH on 
the renal vitamin K-dependent carboxylating system are mediated by 1,25(OH)>D,. 
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1. INTRODUCTION 
Vitamin K participates in the posttranslational 
y-glutamyl carboxylation of proteins other than 
vitamin K-dependent coagulation factors [l-3]. 
Prominent among these is the bone y- 
carboxyglutamic acid containing protein known as 
bone Gla protein or osteocalcin [4,5]; this protein 
is synthesized and secreted from bone cells follow- 
ing carboxylation [6,7]. While several aboratories 
have carried out extensive studies on BGP, no 
definite physiologic role has been assigned to the 
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Abbreviations: Gla, y-carboxyglutamic acid; BGP, bone 
Gla protein; 1,25(OH)zDs, 1,25-dihydroxycholecalci- 
ferol; PTH, parathyroid hormone; FLEEL, the pen- 
tapeptide phenylalanyl-leucyl-glutamyl-glutamyl-leucine 
protein. However, it has been demonstrated in rat 
osteosarcoma cell culture [8] that BGP synthesis 
and secretion are stimulated by 1,25(OH)~D3. A 
less well-characterized vitamin K-dependent pro- 
tein is that found in kidney [9]. The renal vitamin 
K-dependent carboxylating system, which utilizes 
this protein as a substrate and has characteristics 
similar to the liver carboxylating system, has been 
localized to renal tubules and not to glomeruli [lo], 
with the majority of enzyme found in the proximal 
tubule. 
Although the physiological significance of the 
renal carboxylating system is unknown, we have 
shown that the in vitro activity of the renal vitamin 
K-dependent y-glutamyl carboxylase toward syn- 
thetic oligopeptide substrates is stimulated by the 
prior administration of either of the calcemic hor- 
mones, PTH or 1,25(OH)~D3, to rats [ 111. Here we 
report that administration of 1,25(OH)~D3 to rats 
increases their levels of endogenous carboxylase 
substrates as well. 
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2. MATERIALS AND METHODS 
1,25(OH)zDs was a generous gift from Hoffman 
LaRoche. Triton X-100 and vitamin K were pur- 
chased from Sigma; NaH14COJ (50 mCi/mmol) 
from ICN Pharmaceuticals; the pentapeptide 
FLEEL from Vega Biochemicals; Calcium Rapid 
Stat Diagnostic Kit from Lancer; Dowex AG l-X8 
(- 400 mesh) from Bio-Rad; and Liquiscint from 
National Diagnostics. 
In experiments designed to determine the dose- 
response relationship between endogenous 
substrate levels and 1,25(OH)~D3, normal male 
Sprague-Dawley rats (Charles River Breeding 
Laboratories) were given daily injections of 
1,25(OH)2D3 (0.5, 1 .O or 1.5 rig/g body wt) for 7 
days. The time course of the response was deter- 
mined with daily injections of 1,25(OH)~D3 
(1 rig/g body wt) for up to 7 days. In each experi- 
ment rats were killed 1 day after the last injection, 
and blood samples and kidneys were obtained. 
In experiments designed to study the effect of 
vitamin D deficiency and 1,25(OH)zD3 treatment 
on the carboxylating system, weanling male 
Holtzman rats (Holtzman, Madison, WI) were 
maintained on vitamin D-deficient diet (Bioserve) 
for 8 weeks. A group of these rats was sup- 
plemented with 100 IU vitamin D3 orally 3 times 
per week. A second group received intraperitoneal 
injections of 1,25(OH)zD3 (1 rig/g body wt) daily 
during the last 7 days of the experimental period. 
The last injection was given 2 h before killing and 
blood samples were obtained from the abdominal 
aorta of each rat under ether anesthesia for deter- 
minations of serum calcium, vitamin D 
metabolites and PTH. Vitamin D metabolites were 
assayed according to Shepard et al. [12] and PTH 
was assayed by a nonequilibrium radioim- 
munoassay using chicken 12 antibovine PTH an- 
tiserum which crossreacts with rat PTH [ 131. The 
rats were then exsanguinated before the kidneys 
were removed for carboxylase assays. 
Preparation of renal microsomes and determina- 
tion of carboxylase activity with FLEEL were as 
described [ IO,1 I]. Protein carboxylation in intact 
resuspended microsomes in a final reaction volume 
of 500 1 was also carried out as described [I 11. 
Following a 30 min incubation at 37”C, the reac- 
tions were stopped with the addition of 25 ~1 of 
10% Triton X-100 and 28 ~1 of 4.4 N acetic acid. 
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Incubation tubes were then placed on ice for 
10 min. Protein was precipitated with 10% 
trichloroacetic acid and pelleted by centrifugation. 
The pellet was washed with Hz0 and then 
hydrolyzed in 400 ~1 of 2 M KOH at 110°C for 
16 h in a sealed glass tube. Following hydrolysis 
samples were neutralized with HC104 and KC104 
was removed by centrifugation. The supernatant 
(400~1) was applied to a Dowex l-X8 column 
(0.6x 4 cm), which was equilibrated with 0.75 M 
ammonium acetate, pH 4.9. Fractions (1 ml) were 
collected and counted for radioactivity fixed in Gla 
as described in [I 11. 
Protein was determined by a modified method 
of Lowry et al. [ 141 using bovine serum albumin as 
Table 1 
Renal carboxylase ndogenous ubstrate and serum 
calcium levels after 1,25(OH)zD3 treatment 
A. Time-dependent responses to 1,25(OH)zDs treatment 
(1 rig/g body wt) 
Treatment Day Endogenous Serum calcium 
carboxylationa (mg/lOO ml 
(cpm/mg protein + SD) 
f SD) 
Vehicle 0 13.5 + 3.0 9.9 2 0.3 
7 11.2 +- 0.7 9.8 + 0.8 
1,25(OH)zD3 1 13.9 k 1.0 11.2 * 1.1 
2 27.5 -t 2.8’ 12.1 I!T 1.1 
4 72.9 k 7.2b 14.2 + 0.8 
7 56.9 rt 6.Sb 14.1 f 1.1 
B. Dose-dependent responses to 1,25(OH)zDs treatment 
for 7 days 
1,25(OH)zD3 Endogenous carboxyl- Serum calcium 
(ng/g) ation (cpm/mg (mg/lOO ml 
protein f SD) + SD) 
0.0 11.5 + 0.5 9.4 + 0.4 
0.5 31.8 + 2.5b 13.3 + 0.7 
1.0 53.6 f 2.3b 14.3 * 0.1 
1.5 31.8 f 1.4b 14.3 * 0.4 
a Carboxylation reactions were carried out as described 
in section 2 except that renal microsomes were pooled 
from 3 rats for each treatment 
b Significantly different from control (vehicle only) as 
determined by the Student’s f-test (P I 0.001) 
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Table 2 
Serum PTH, vitamin D metabolites and calcium levels 
Treatment PTH 
(pg/mDb 
25(OH)D 
(ngjml) 
1,25(OH)zD Serum calciuma 
(pglml) (mg%) 
-D 3582 + 562 Undetectable 78.6 f 12.5 7.91 + 1.4 
+D’ Undetectable 12.3 f 3.3 150.5 f 18.6 10.10 f 0.4 
- D + 1 ,25(OH)2Dsd Undetectable Undetectable >500 13.50 f 2.1 
a All serum data are mean + SD from 5 rats 
b pg equivalents to bovine PTH/ml. The normal PTH level is 333 + 38 
’ Rats on the vitamin D-deficient diet were made vitamin D replete by giving them 100 IU 
vitamin D; orally 3 times/week 
d Daily intraperitoneal injections of 1,25(OH)zD3 (1 rig/g body wt) were administered 
during the last 7 days on vitamin D-deficient diet 
a standard [15]. Radioactivity was assayed with a calcium. The serum PTH level was high in rats fed 
Beckman LS-250 liquid scintillation system. The the vitamin D-deficient diet but was undetectable 
Student’s t-test was used for statistical analyses. in the other 2 groups. Serum 25(OH)D was 
3. RESULTS 
Table 3 
In our earlier study dose-response and time 
dependency relationships for the effect of 
1,25(OH)~D3 on renal FLEEL carboxylase activity 
was reported but such relationships for the effect 
of the hormone on endogenous substrate levels 
were not [ll]. Daily 1,25(OH)~D3 injections 
(1 rig/g body wt) in vitamin D-replete rats led to an 
increase in serum calcium discernible after 1 day: 
a statistically significant increase in the carbox- 
ylase substrate level was observed after 2 days of 
1,25(OH)~D3 treatment and a maximal response 
was measured after 4 days of treatment at which 
time the substrate lebel of the treated group was 
5.4-fold higher than that of the control group 
(table 1). Maximal elevation of serum calcium to 7 
daily doses of 1,25(OH)zD3 was observed at 1 rig/g 
body wt. Renal carboxylase substrate level was in- 
creased 2%fold following treatment with 0.5 rig/g 
body wt, while at 1 rig/g body wt the increase was 
4.7-fold. At the highest dose (1.5 rig/g body wt) 
the increase was less than at 1 rig/g body wt, a 
result compatible with the occurrence of a toxic 
response at this level. 
Effects of vitamin D status on renal carboxylase 
substrate level and carboxylase activity 
Treatment Carboxylation 
(cpm/mg protein f SD) 
As shown in table 2 serum calcium was lower in 
rats fed vitamin D-deficient diet for 8 weeks than 
in vitamin D-supplemented rats; rats receiving 
1,25(OH)~D3 treatment during the final week of 
the experiment had elevated levels of serum 
Endogenous’ FLEELb 
-D 10.3 f 1.3 1023 f 114 
+D 11.7 * 1.5 967 f 104 
- D + 1,25(OH)zD3 48.7 f 9.8’ 1900 f 34’ 
a Rats were maintained on vitamin D-deficient diet for 
8 weeks. Endogenous substrate levels were determined 
in triplicate in carboxylase assays using intact 
resuspended renal microsomes pooled from 5 rats. 
Each reaction mixture contained 10 mg resuspended 
microsomal protein. Incubations and assays for 
[14C]Gla are as described in section 2. Vitamin K- 
independent fixed 14C eluting at the Gla position was 
less than 1 cpm/mg protein 
b Carboxylase activity was determined using FLEEL as 
the substrate in solubilized microsomes [ 171. 
Incubations were in a volume of 12081 at 17°C for 
45 min. The reaction mixture contained lOOpI 
solubilized renal microsomes (3 mg protein), FLEEL 
(4OOpg), NaH14C03 (2.5 &i), and either isopropyl 
alcohol (5 ~1) or vitamin KlH2 in isopropyl alcohol 
(5 ~1). Reactions were stopped with 10% perchloric 
acid and soluble 14C radioactivity was assayed [l 1] 
’ Significantly different from -D and +D as 
determined by the Student’s t-test (P 5 0.01) 
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undetectable both in the rats fed the vitamin D- 
deficient diet and in those treated with 
1,25(OH)~Ds. While high levels of 1,25(OH)zD 
were found in rats treated with 1,25(OH)zD3 serum 
1,25(0H)~D was reduced by only 50% in rats fed 
the vitamin D-deficient diet compared to rats fed 
the vitamin D-deficient diet but given oral vitamin 
D supplement. 
Maintenance of rats on vitamin D-deficient diet 
for 8 weeks did not alter the carboxylase substrate 
level or the carboxylase activity (determined with 
FLEEL as the substrate) when compared to 
vitamin D-supplemented rats (table 3). When rats 
maintained on the vitamin D-deficient diet were 
given daily intraperitoneal injections of 
1,25(OH)2D3 for the last 7 days of the experiment, 
a nearly 5-fold increase in the substrate level and, 
as demonstrated in [l 11, a stimulation of FLEEL 
carboxylase activity (table 3), resulted. 
deficient diet displayed decreased serum calcium, 
increased PTH and undetectable 25(OH)D, serum 
1,25(OH)zD was still present at detectable levels. 
Thus, either carboxylase activity and substrate 
level are not altered by vitamin D deficiency or a 
reduction in 1,25(OH)zD levels greater than the 
50070 reduction achieved in this study is necessary 
for any alterations to become manifest. Further 
study is needed to clarify this point. 
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